Methadone Expansion in Detention Though the Hospital/Clinic Designation

Thursday, July 16, 2026 12:00 AM

Conditions: Opioid Use Disorder; Incarcerated Individuals; Methadone Maintenance Interventions: Other: Learning Collaborative Sponsors: Brendan Saloner; National Institute on Drug Abuse (NIDA); Johns Hopkins Bloomberg School of Public ...

A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

Wednesday, July 15, 2026 12:00 AM

Conditions: Parkinson's Disease (PD) Interventions: Device: Digital Music Device (MedRhythms, Inc., Portland, ME) Sponsors: Boston University Charles River Campus; Michael J. Fox Foundation for Parkinson's Research; University of Utah; ...

Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia

Friday, July 10, 2026 12:00 AM

Conditions: Pain, Postoperative Interventions: Drug: Standard Bupivacaine; Drug: Liposomal Bupivacaine Sponsors: Washington University School of Medicine Not yet recruiting

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

Monday, July 6, 2026 12:00 AM

Conditions: Mycosis Fungoides/Sezary Syndrome; T-cell Large Granular Lymphocytic Leukemia Interventions: Drug: Golidocitinib Sponsors: Washington University School of Medicine; Dizal Pharmaceuticals Not yet recruiting

Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer

Wednesday, July 8, 2026 12:00 AM

Conditions: Breast Cancer; Advanced Breast Cancer; Metastatic Breast Cancer Interventions: Drug: Trastuzumab deruxtecan; Drug: Lovastatin Sponsors: Washington University School of Medicine; National Cancer Institute (NCI) Not yet recruiting

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

Wednesday, July 15, 2026 12:00 AM

Conditions: Long-acting Injectable Cabotegravir for PrEP; Oral Pre-Exposure Prophylaxis (PrEP) Interventions: Behavioral: Tracing Strategy Sponsors: Johns Hopkins Bloomberg School of Public Health; National Institute of Mental Health (NIMH); ...

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

Monday, July 6, 2026 12:00 AM

Conditions: Small-cell Lung Cancer; Small Cell Lung Cancer Extensive Stage Interventions: Drug: DSP-0390; Drug: Atezolizumab Sponsors: Washington University School of Medicine; Sumitomo Pharma America, Inc. Not yet recruiting

Motixafortide for MRD Sensitization in AML

Monday, July 6, 2026 12:00 AM

Conditions: Acute Myeloid Leukemia; Measurable Residual Disease Interventions: Drug: Motixafortide Sponsors: Washington University School of Medicine; Gamida Cell ltd Not yet recruiting